DE60006519D1 - Glutathion-reduktase zur behandlung und prophylaxe von aids - Google Patents

Glutathion-reduktase zur behandlung und prophylaxe von aids

Info

Publication number
DE60006519D1
DE60006519D1 DE60006519T DE60006519T DE60006519D1 DE 60006519 D1 DE60006519 D1 DE 60006519D1 DE 60006519 T DE60006519 T DE 60006519T DE 60006519 T DE60006519 T DE 60006519T DE 60006519 D1 DE60006519 D1 DE 60006519D1
Authority
DE
Germany
Prior art keywords
aids
treatment
prophylaxis
reductase
glutathion reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006519T
Other languages
English (en)
Other versions
DE60006519T2 (de
Inventor
Raffaele Ansovini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60006519D1 publication Critical patent/DE60006519D1/de
Application granted granted Critical
Publication of DE60006519T2 publication Critical patent/DE60006519T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
DE60006519T 1999-05-21 2000-03-28 Glutathion-reduktase zur behandlung und prophylaxe von aids Expired - Lifetime DE60006519T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI991122 1999-05-21
IT1999MI001122A IT1312569B1 (it) 1999-05-21 1999-05-21 Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
PCT/EP2000/002703 WO2000071146A2 (en) 1999-05-21 2000-03-28 Glutathione reductase for therapy and prophylaxis of aids

Publications (2)

Publication Number Publication Date
DE60006519D1 true DE60006519D1 (de) 2003-12-18
DE60006519T2 DE60006519T2 (de) 2004-06-03

Family

ID=11383014

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006519T Expired - Lifetime DE60006519T2 (de) 1999-05-21 2000-03-28 Glutathion-reduktase zur behandlung und prophylaxe von aids

Country Status (12)

Country Link
US (1) US7045323B2 (de)
EP (1) EP1178819B1 (de)
JP (1) JP2003519088A (de)
AT (1) ATE253936T1 (de)
AU (1) AU4111600A (de)
DE (1) DE60006519T2 (de)
DK (1) DK1178819T3 (de)
ES (1) ES2211532T3 (de)
HK (1) HK1045258B (de)
IT (1) IT1312569B1 (de)
PT (1) PT1178819E (de)
WO (1) WO2000071146A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
ITMI20010760A1 (it) * 2001-04-10 2002-10-10 Raffaele Ansovini Associazione di enzimi coadiuvante nella terapia con interferone
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20120244212A1 (en) * 2004-11-07 2012-09-27 Frederick Timothy Guilford Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione
DE602006020434D1 (de) * 2005-05-17 2011-04-14 Santen Pharmaceutical Co Ltd Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor
IT1393875B1 (it) * 2009-04-29 2012-05-11 Medestea Res & Production S P A Coniugato glutatione reduttasi-peg e suo impiego come medicamento antinfluenzale
IT1401504B1 (it) * 2010-08-02 2013-07-26 Cattarini Mastelli Composizione comprendente glutatione reduttasi e glutatione ossidato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2928417A1 (de) * 1979-07-12 1981-01-29 Schering Ag Trijodierte basen
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
EP0759303B1 (de) * 1994-04-22 2002-10-16 Yamanouchi Pharmaceutical Co. Ltd. Kolon-spezifisches arzneistofffreisetzungssystem
IL123887A0 (en) * 1997-04-02 1998-10-30 Sankyo Co Dithiolan derivatives their use and pharmaceutical compositions containing the same
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms
IT1312569B1 (it) 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.

Also Published As

Publication number Publication date
ATE253936T1 (de) 2003-11-15
ITMI991122A1 (it) 2000-11-21
AU4111600A (en) 2000-12-12
EP1178819B1 (de) 2003-11-12
EP1178819A2 (de) 2002-02-13
WO2000071146A3 (en) 2001-03-01
DK1178819T3 (da) 2004-02-02
PT1178819E (pt) 2004-04-30
IT1312569B1 (it) 2002-04-22
ES2211532T3 (es) 2004-07-16
DE60006519T2 (de) 2004-06-03
JP2003519088A (ja) 2003-06-17
US20040223958A1 (en) 2004-11-11
HK1045258A1 (en) 2002-11-22
WO2000071146A2 (en) 2000-11-30
US7045323B2 (en) 2006-05-16
HK1045258B (zh) 2004-04-02

Similar Documents

Publication Publication Date Title
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
AU2002360592A8 (en) Inhibitors of hepatitis c virus
MXPA04003796A (es) Tioacetamidas sustituidas.
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60006519D1 (de) Glutathion-reduktase zur behandlung und prophylaxe von aids
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE422944T1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
ATE264101T1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
WO2003045428A3 (de) Verwendung einer technisch veränderten zelle als vakzine zur behandlung einer tumorerkrankung
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
DE50012015D1 (de) Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
AU7477101A (en) Human site-1 protease promoter
MX9503363A (es) N-(2,6-dioxo-3-piperidil) ftalimida (generico talidomida como tratamiento del sindrome de desgaste asociado con la infeccion por vih-1.
PT1355650E (pt) Combinacao de ingredientes activos contendo alfuzosina e apomorfina
AU2002303133A1 (en) Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition